title: [Atovaquone-proguanil treatment failure in Plasmodium falciparum].
authors.forename: Laetitia
authors.initials: L
authors.lastname: Contentin
authors.forename: Leslie
authors.initials: L
authors.lastname: Grammatico-Guillon
authors.forename: Guillaume
authors.initials: G
authors.lastname: Desoubeaux
authors.forename: Sabine
authors.initials: S
authors.lastname: Baron
authors.forename: Hai Duong
authors.initials: HD
authors.lastname: Thanh
mesh_terms: D000328:Adult; D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use*; D053626:Atovaquone / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004338:Drug Combinations; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D054242:Emigrants and Immigrants; D005602:France; D016701:Guinea / Q000208:ethnology; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy*; D008297:Male; D010963:Plasmodium falciparum / Q000187:drug effects; D002727:Proguanil / Q000009:adverse effects / Q000627:therapeutic use*; D011803:Quinine / Q000009:adverse effects / Q000627:therapeutic use; D012008:Recurrence; D014195:Travel; D017211:Treatment Failure
chemical_list: D000962:Antimalarials; D004338:Drug Combinations; C109496:atovaquone, proguanil drug combination; D011803:Quinine; D002727:Proguanil; D053626:Atovaquone